Q4 2025 13F Holders as of 31 Dec 2025
-
Type / Class
-
Equity / Common Stock, no par value
-
Shares outstanding
-
34,382,284
-
Total 13F shares
-
2,271,449
-
Share change
-
-60,615
-
Total reported value
-
$3,021,166
-
Price per share
-
$1.33
-
Number of holders
-
32
-
Value change
-
-$87,478
-
Number of buys
-
11
-
Number of sells
-
13
Institutional Holders of Telomir Pharmaceuticals, Inc. - Common Stock, no par value (TELO) as of Q4 2025
As of 31 Dec 2025,
Telomir Pharmaceuticals, Inc. - Common Stock, no par value (TELO) was held by
32 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
2,271,449 shares.
The largest 10 holders included
VANGUARD GROUP INC, BlackRock, Inc., GEODE CAPITAL MANAGEMENT, LLC, MILLENNIUM MANAGEMENT LLC, STATE STREET CORP, Bank of New York Mellon Corp, Suncoast Equity Management, NORTHERN TRUST CORP, XTX Topco Ltd, and World Investment Advisors.
This page lists
33
institutional shareholders reporting positions in this security
for the Q4 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.